Progyny, Inc. PGNY

25.44 (0.53) (2.04%) as of 25 Sep
Market cap
$2.0B
P/E
26.2×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

11.37% 12.48% 14.93% 16.24%
ROA
7.77% 8.67% 9.48% 10.65%
ROIC
24.98% 25.88% 28.15% 32.40%
Return on Tangible Assets
12.97% 15.43% 22.45% 24.97%
Average Days of Receivables
72.64 62.39 74.41 71.70
Free Cash Flow per Share
2.25 2.24 2.28 2.28
Free Cash Flow
193.46 191.78 184.42 178.38
Capital Expenditures
(14.69) (18.41) (21.91) (22.86)
Piotroski F-Score
6.00 6.00 6.00 6.00
Other line items
Cash ROIC
22.99% 25.44% 31.05% 29.16%
Accounts Receivable Turnover
4.76 5.66 4.59 4.95
Accounts Payable Turnover
7.71 8.98 6.47 6.76
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
45.95 46.01 58.70 56.13
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.41) (0.39) (0.36) (0.34)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
16.17% 17.01% 16.65% 16.02%
Share Based Compensation of Revenue
10.08% 10.23% 9.21% 8.18%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
3.68 3.59 3.05 2.56
Depreciation/Fixed assets
0.31 0.17 0.15 0.14
Capex/Depreciation
(1.89) (3.72) (4.12) (3.98)
Revenue per Share
14.75 15.05 15.98 16.77
Operating CF per Share
2.42 2.45 2.55 2.57
Capex per Share
(0.17) (0.21) (0.27) (0.29)
Capex to Sales
0.01 0.01 0.02 0.02
Net Profit Margin
4.46% 4.54% 5.23% 6.00%

Fold the line items

Columns are period end dates